PubRank

Sarah L Rowland-Jones

Author PubWeight™ 89.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002 10.03
2 Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004 3.20
3 Characterization of CD4(+) CTLs ex vivo. J Immunol 2002 3.10
4 Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol 2008 2.59
5 Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS 2002 1.92
6 Lessons from the study of T-cell differentiation in persistent human virus infection. Semin Immunol 2004 1.89
7 Acute cytomegalovirus infection in Kenyan HIV-infected infants. AIDS 2009 1.87
8 Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 2003 1.85
9 A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J Gen Virol 2004 1.80
10 Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J Virol 2005 1.74
11 HIV-2: the forgotten AIDS virus. Trends Microbiol 2008 1.66
12 HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med 2004 1.60
13 Premature ageing of the immune system: the cause of AIDS? Trends Immunol 2002 1.55
14 Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment. J Immunol 2010 1.45
15 Dynamics of T cell responses in HIV infection. J Immunol 2002 1.44
16 Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol 2010 1.42
17 Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS 2005 1.40
18 Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J Immunol 2006 1.36
19 The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining. J Immunol Methods 2002 1.28
20 Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. AIDS Res Hum Retroviruses 2007 1.23
21 Deep analysis of cellular transcriptomes - LongSAGE versus classic MPSS. BMC Genomics 2007 1.21
22 Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J Immunol 2010 1.20
23 Viral coinfections among African children infected with human immunodeficiency virus type 1. Clin Infect Dis 2003 1.18
24 High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphism. J Immunol 2012 1.16
25 Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retroviruses 2002 1.14
26 Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection. J Immunol 2006 1.09
27 The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS 2009 1.09
28 Correlates of delayed disease progression in HIV-1-infected Kenyan children. J Immunol 2005 1.05
29 Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections. J Infect Dis 2011 1.05
30 Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women. AIDS 2003 1.02
31 The T cell surface--how well do we know it? Immunity 2003 1.01
32 Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. Blood 2011 1.01
33 HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis. AIDS 2004 1.00
34 The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life. PLoS One 2010 1.00
35 Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load. J Clin Immunol 2002 0.99
36 Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses. Eur J Immunol 2006 0.96
37 Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings. AIDS Res Treat 2011 0.96
38 Characterization of an HLA-C-restricted CTL response in chronic HIV infection. Eur J Immunol 2010 0.93
39 Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection. J Virol 2007 0.92
40 Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies. J Virol 2012 0.90
41 Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine. PLoS One 2013 0.89
42 Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants. Vaccine 2005 0.89
43 Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection. Blood 2013 0.89
44 Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS 2002 0.89
45 HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades. AIDS 2002 0.88
46 The antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate. PLoS Pathog 2011 0.87
47 Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa. J Virol 2010 0.87
48 Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms. Proc Natl Acad Sci U S A 2012 0.86
49 The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life. Front Immunol 2012 0.86
50 Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia. Eur J Immunol 2008 0.86
51 HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate. AIDS 2002 0.85
52 Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants. J Virol 2012 0.85
53 Phenotypic characterization of HIV-specific CD8+ T cells during early and chronic infant HIV-1 infection. PLoS One 2011 0.84
54 A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais. PLoS One 2011 0.83
55 HIV and chemokine binding to red blood cells--DARC matters. Cell Host Microbe 2008 0.82
56 Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression. J Virol 2009 0.81
57 Gonococcal cervicitis is associated with reduced systemic CD8+ T cell responses in human immunodeficiency virus type 1-infected and exposed, uninfected sex workers. J Infect Dis 2002 0.81
58 An underestimated lentivirus model: what can HIV-2 research contribute to the development of an effective HIV-1 vaccine? Expert Rev Anti Infect Ther 2011 0.80
59 A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants. PLoS One 2013 0.80
60 Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization. Clin Perinatol 2010 0.80
61 The HIV protease inhibitor indinavir reduces immature dendritic cell transendothelial migration. Eur J Immunol 2003 0.79
62 HLA correlates in a cohort of slow progressors from China: effects on HIV-1 disease progression. AIDS 2013 0.78
63 Functional differences exist between TNFα promoters encoding the common -237G SNP and the rarer HLA-B*5701-linked A variant. PLoS One 2012 0.77
64 Differential remodeling of a T-cell transcriptome following CD8- versus CD3-induced signaling. Cell Res 2008 0.77
65 HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form. Retrovirology 2010 0.77
66 Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev. AIDS 2006 0.76
67 Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa. Int J Infect Dis 2012 0.76
68 Immune approaches for the prevention of breast milk transmission of HIV-1. Adv Exp Med Biol 2012 0.75
69 HLA Correlates of Long-Term Survival in Vertically Infected HIV-1-Positive Adolescents in Harare, Zimbabwe. AIDS Res Hum Retroviruses 2015 0.75
70 Predicting the extinction of HIV-2 in rural Guinea-Bissau. AIDS 2015 0.75
71 HIV: Bad news for stop--start therapy? Nature 2002 0.75
72 Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants. AIDS 2017 0.75